Hereditäres Angioödem (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hereditäres Angioödem" in German language version.

refsWebsite
Global rank German rank
2nd place
3rd place
123rd place
6th place
610th place
521st place
274th place
152nd place
low place
4,962nd place
222nd place
272nd place
4th place
7th place
2,650th place
1,472nd place
507th place
750th place

altmeyers.org

doi.org

  • Emel Aygören-Pürsün, Konrad Bork: Hereditäres Angioödem. In: Der Internist. Band 60, Nr. 9, September 2019, ISSN 0020-9554, S. 987–995, doi:10.1007/s00108-019-0644-1 (springer.com [abgerufen am 12. Februar 2020]).
  • Aleena Banerji, Neelam A. Phadke, Ravi Gottumukkala, Rohit Sharma, Mandakolathur R. Murali: Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling. New England Journal of Medicine 2022, Band 386, Ausgabe 11 vom 17. März 2022, Seiten 1071–1079, DOI: 10.1056/NEJMcpc2027087
  • Markus Magerl, Anastasios E. Germenis, Coen Maas, Marcus Maurer: Hereditary Angioedema with Normal C1 Inhibitor. In: Immunology and Allergy Clinics of North America. Band 37, Nr. 3, August 2017, S. 571–584, doi:10.1016/j.iac.2017.04.004 (elsevier.com [abgerufen am 12. Februar 2020]).
  • M. Maurer, M. Magerl, I. Ansotegui, E. Aygören-Pürsün, S. Betschel: The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. In: Allergy. Band 73, Nr. 8, August 2018, S. 1575–1596, doi:10.1111/all.13384 (wiley.com [abgerufen am 12. Februar 2020]).
  • Jonathan A. Bernstein: On-demand Therapy for Hereditary Angioedema. In: Immunology and Allergy Clinics of North America. Band 33, Nr. 4, November 2013, S. 487–494, doi:10.1016/j.iac.2013.07.004 (elsevier.com [abgerufen am 12. Februar 2020]).
  • Timothy Craig, Bruce Zuraw, Hilary Longhurst, Marco Cicardi, Konrad Bork: Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. In: The Journal of Allergy and Clinical Immunology: In Practice. Band 7, Nr. 6, Juli 2019, S. 1793–1802.e2, doi:10.1016/j.jaip.2019.01.054 (elsevier.com [abgerufen am 12. Februar 2020]).
  • Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein, Marco Cicardi, Hilary J. Longhurst: Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. In: JAMA. Band 320, Nr. 20, 27. November 2018, ISSN 0098-7484, S. 2108, doi:10.1001/jama.2018.16773, PMID 30480729, PMC 6583584 (freier Volltext) – (jamanetwork.com [abgerufen am 12. Februar 2020]).
  • V. Zampeli, M. Magerl: Prophylaxe von Angioödemen. In: Der Hautarzt. Band 70, Nr. 2, Februar 2019, ISSN 0017-8470, S. 107–115, doi:10.1007/s00105-018-4345-9 (springer.com [abgerufen am 12. Februar 2020]).
  • Francesca Perego, Maddalena A. Wu, Anna Valerieva, Sonia Caccia, Chiara Suffritti: Current and emerging biologics for the treatment of hereditary angioedema. In: Expert Opinion on Biological Therapy. Band 19, Nr. 6, 3. Juni 2019, ISSN 1471-2598, S. 517–526, doi:10.1080/14712598.2019.1595581 (tandfonline.com [abgerufen am 12. Februar 2020]).

elsevier.com

linkinghub.elsevier.com

  • Markus Magerl, Anastasios E. Germenis, Coen Maas, Marcus Maurer: Hereditary Angioedema with Normal C1 Inhibitor. In: Immunology and Allergy Clinics of North America. Band 37, Nr. 3, August 2017, S. 571–584, doi:10.1016/j.iac.2017.04.004 (elsevier.com [abgerufen am 12. Februar 2020]).
  • Jonathan A. Bernstein: On-demand Therapy for Hereditary Angioedema. In: Immunology and Allergy Clinics of North America. Band 33, Nr. 4, November 2013, S. 487–494, doi:10.1016/j.iac.2013.07.004 (elsevier.com [abgerufen am 12. Februar 2020]).
  • Timothy Craig, Bruce Zuraw, Hilary Longhurst, Marco Cicardi, Konrad Bork: Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. In: The Journal of Allergy and Clinical Immunology: In Practice. Band 7, Nr. 6, Juli 2019, S. 1793–1802.e2, doi:10.1016/j.jaip.2019.01.054 (elsevier.com [abgerufen am 12. Februar 2020]).

jamanetwork.com

jama.jamanetwork.com

  • Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein, Marco Cicardi, Hilary J. Longhurst: Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. In: JAMA. Band 320, Nr. 20, 27. November 2018, ISSN 0098-7484, S. 2108, doi:10.1001/jama.2018.16773, PMID 30480729, PMC 6583584 (freier Volltext) – (jamanetwork.com [abgerufen am 12. Februar 2020]).

nih.gov

ncbi.nlm.nih.gov

  • Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein, Marco Cicardi, Hilary J. Longhurst: Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. In: JAMA. Band 320, Nr. 20, 27. November 2018, ISSN 0098-7484, S. 2108, doi:10.1001/jama.2018.16773, PMID 30480729, PMC 6583584 (freier Volltext) – (jamanetwork.com [abgerufen am 12. Februar 2020]).

springer.com

link.springer.com

tandfonline.com

  • Francesca Perego, Maddalena A. Wu, Anna Valerieva, Sonia Caccia, Chiara Suffritti: Current and emerging biologics for the treatment of hereditary angioedema. In: Expert Opinion on Biological Therapy. Band 19, Nr. 6, 3. Juni 2019, ISSN 1471-2598, S. 517–526, doi:10.1080/14712598.2019.1595581 (tandfonline.com [abgerufen am 12. Februar 2020]).

wiley.com

doi.wiley.com

  • M. Maurer, M. Magerl, I. Ansotegui, E. Aygören-Pürsün, S. Betschel: The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. In: Allergy. Band 73, Nr. 8, August 2018, S. 1575–1596, doi:10.1111/all.13384 (wiley.com [abgerufen am 12. Februar 2020]).

zdb-katalog.de